Table 5.
Instrument | HIV–No SN (n = 38) | HIV-SN with pain (n = 21) | P |
---|---|---|---|
ISI | |||
Mean ISI total score (/28) | 10.16 ± 7.86 | 14.05 ± 8.86 | .112 |
Participants with clinical insomnia (ISI ⩾15) | 7 (22.6%) | 13 (68.4%) | <.001 |
Participants with severe insomnia (ISI ⩾22) | 3 (9.7%) | 7 (22.6%) | <.001 |
DAPOS | |||
DAPOS depression (/25) | 8.38 ± 4.10 | 11.21 ± 4.22 | <.05 |
DAPOS anxiety (/15) | 5.45 ± 2.89 | 7.47 ± 2.97 | <.05 |
PASS-20 | |||
PASS cognitive (/25) | 8.45 ± 5.28 | 14.95 ± 5.69 | <.001 |
PASS escape-avoidance (/25) | 9.07 ± 7.15 | 11.84 ± 6.38 | .177 |
PASS fear (/25) | 6.97 ± 7.11 | 11.79 ± 6.75 | <.05 |
PASS physiological anxiety (/25) | 4.83 ± 6.45 | 9.21 ± 7.54 | <.05 |
PASS total (/100) | 35.84 ± 29.84 | 47.79 ± 21.94 | .136 |
PCS | |||
PCS rumination (/16) 5.68 ± 4.85 | 8.84 ± 5.11 | 0.330 | |
PCS magnification (/12) | 3.97 ± 3.66 | 5.63 ± 3.39 | .115 |
PCS helplessness (/24) | 6.03 ± 5.52 | 11.16 ± 6.131 | <.02 |
PCS total (/52) | 14.13 ± 11.81 | 23.74 ± 12.64 | <.02 |
BPI | |||
BPI interference (/70) | 15.20 ± 16.22 | 46.11 ± 13.69 | <.001 |
SF-36 | |||
Physical Functioning (PF) | 74.03 ± 24.65 | 34.47 ± 21.74 | <.001 |
Role Physical (RP) | 50.78 ± 43.76 | 11.84 ± 28.10 | <.001 |
Bodily Pain (BP) | 69.43 ± 24.47 | 29.42 ± 18.06 | <.001 |
General Health (GH) | 43.78 ± 26.96 | 26.58 ± 19.88 | <.05 |
Vitality (VT) | 49.53 ± 24.08 | 25.79 ± 24.45 | <.001 |
Social Functioning (SF) | 67.98 ± 27.31 | 32.24 ± 24.41 | <.001 |
Role Emotional (RE) | 54.17 ± 46.18 | 15.79 ± 32.14 | <.05 |
Mental Health (MH) | 63.25 ± 21.25 | 47.79 ± 17.05 | <.05 |
HIV-SN, HIV sensory neuropathy; HIV–No SN, no HIV sensory neuropathy; ISI, Insomnia Severity Index; DAPOS, Depression Anxiety Positive Outlook Scale; PASS-20, Pain Anxiety Symptom Scale Short Form; PCS, Pain Catastrophizing Scale; SF-36, Short Form (36) Health Survey.